Article By:
Zacks Investment Research
Sunday, February 26, 2023 7:19 PM EDT
The company’s adjusted earnings per share of $1.02, which beat the Zacks Consensus Estimate of 92 cents and our estimate of 84 cents but decreased from $1.29 reported in the year-ago quarter.
In this article: BHC
Generic Industry On Path To Recovery: 3 Hot Picks For 2019
I thought $BHC didn't make generics?